Sensitization of cutaneous primary afferents in bone cancer revealed by in vivo calcium imaging
Larissa de ClauseriD, Ana Paula LuiziD, Sonia Santana‐VarelaiD, John N. WoodiD, Shafaq SikandariD
Abstract
Cancer-induced bone pain (CIBP) is a complex condition comprising components of inflammatory and neuropathic processes, but changes in the physiological response profiles of bone-innervating afferents remain poorly understood. We used a combination of retrograde labelling and in vivo calcium imaging of bone marrow-innervating DRG neurons to determine the contribution of these cells in the establishment and maintenance of CIBP. We found a majority of femoral bone afferent cell bodies in L3 DRG that also express the sodium channel subtype Nav1.8 - a marker of nociceptive neurons- and lack expression of parvalbumin - a marker for proprioceptive primary afferents. Surprisingly, the response properties of bone marrow afferents to both increased intraosseous pressure and acid were unchanged by the presence of cancer. On the other hand, we found increased excitability and polymodality of cutaneous afferents innervating the ipsilateral paw in cancer bearing animals, as well as a behavioral phenotype that suggests changes at the level of the DRG contribute to secondary hypersensitivity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 0.90
- Field percentile
- top 26%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The impact of bone cancer on the peripheral encoding of mechanical pressure stimuli
Mateusz Wojciech Kucharczyk, Kim I. Chisholm, … Stephen Brendan McMahon·PainPeer-reviewed·Apr 13, 2020
- Novel therapies for cancer-induced bone pain
Rayan Haroun, Samuel J. Gossage, … John N. Wood·Neurobiology of PainPeer-reviewed·Jul 1, 2024
- CCR2 silencing in sensory neurons blocks bone cancer progression
Élora Midavaine, Jérôme Côté, … Philippe Sarret·bioRxiv·May 29, 2024
- Netrin-1 inhibition does not attenuate cancer-induced bone pain in three translational models
Chelsea Hopkins, Mie Brandt Lassen, … Anne‐Marie Heegaard·bioRxiv·Jul 13, 2026
- The stage specific plasticity of descending modulatory controls in a rodent model of cancer induced bone pain
Mateusz Wojciech Kucharczyk, Diane Derrien, … Kirsty Bannister·CancersPeer-reviewed·Nov 6, 2020
- CCR2-targeting pepducins reduce T cell-nociceptor interaction driving bone cancer pain
Élora Midavaine, Rebecca L. Brouillette, … Philippe Sarret·bioRxiv·Sep 15, 2023